Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...
Amgen drug leads to up to 20% weight loss in trial
Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...
Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies
Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...
Amgen posts mid-stage data for weight loss therapy
Amgen (AMGN) stock slips as company posts mid-stage trial data for weight loss therapy MariTide. Rivals Eli Lilly (LLY) and Novo Nordisk (NVO) gain. Read more here.
Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Investing in Pharma Stocks? Check These 3 Things First
The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...
Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says
Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
Medscape5d
Vagus Nerve Stimulation Proves Effective in Refractory Rheumatoid Arthritis
The novel therapy, delivered via implantable, pill-sized device, improved RA signs and symptoms in patients receiving daily ...
Medscape6d
Long-Term Risk for Autoimmune, Autoinflammatory Skin Disorders Increased After COVID-19
A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...
Amgen's Bids for Judgments Rebuffed in Cancer-Drug Damages Case
Amgen Inc. lost requests for several judgments in Lindis Biotech GmbH’s patent-infringement lawsuit seeking damages for sales of the leukemia treatment Blincyto, according to a federal judge’s mixed ...
BioPharma Dive4d
Amgen picks prolific biotech founder Chang as new top scientist
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...